Ambuja Cements (AMBUJACEM) — Board Meeting

Ambuja Cements held its 42nd AGM on June 26, 2025, with all 16 resolutions passed by overwhelming majorities. Key approvals included adoption of FY2025 financials, dividend declaration, reappointment of Managing Director Ajay Kapur, appointment of Vinod Bahety as Wholetime Director & CEO, and reappointment of independent directors. Material related-party transactions with Adani entities and Orient Cement were approved with 99.99% shareholder support. Total votes polled: 2.24 billion shares (91% of outstanding). Promoter participation was 100%, while public institutions and non-institutions showed strong backing.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this board meeting affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 27 June 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 27 June 2025

ZYDUSLIFE Zydus Lifesciences Limited Financial Results ADANIENT Adani Enterprises Limited Announcement TITAN Titan Company Limited Annual Report RECLTD REC Limited Financial Results SHRIRAMFIN Shriram Finance Limited Financial Results ASIANPAINT Asian Paints Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.